Results for tag: "Hypoactive Sexual Desire Disorder Drug"

Hypoactive Sexual Desire Disorder (HSDD) is a sexual health disorder characterized by a lack of sexual desire or interest in sexual activity. It is the most common form of female sexual dysfunction, affecting up to one in five women. Treatment for HSDD typically involves psychotherapy, lifestyle changes, and medications. The HSDD drug market is a subset of the larger Sexual and Reproductive Health Drugs market. It includes medications that are used to treat HSDD, such as flibanserin, bremelanotide, and testosterone. These drugs are typically prescribed by a healthcare provider and are available in both oral and topical forms. The HSDD drug market is highly competitive, with several major players. These include Sprout Pharmaceuticals, Palatin Technologies, and Emotional Brain. Other companies in the market include Apricus Biosciences, Trimel Pharmaceuticals, and Endoceutics. Show Less Read more